Home302440 • KRX
SK Bioscience Co Ltd
â‚©49,000.00
Jan 31, 4:20:30 PM GMT+9 · KRW · KRX · Disclaimer
Stock
Previous close
â‚©49,550.00
Day range
â‚©48,900.00 - â‚©50,200.00
Year range
â‚©43,650.00 - â‚©65,700.00
Market cap
3.84T KRW
Avg Volume
143.55K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW)Sep 2024Y/Y change
Revenue
61.65B-73.41%
Operating expense
41.34B-7.01%
Net income
-22.32B-146.12%
Net profit margin
-36.20-273.45%
Earnings per share
-290.00—
EBITDA
-30.21B-143.27%
Effective tax rate
27.20%—
Total assets
Total liabilities
(KRW)Sep 2024Y/Y change
Cash and short-term investments
1.34T9.36%
Total assets
2.05T6.64%
Total liabilities
328.20B66.40%
Total equity
1.72T—
Shares outstanding
76.83M—
Price to book
2.21—
Return on assets
-4.93%—
Return on capital
-5.27%—
Net change in cash
(KRW)Sep 2024Y/Y change
Net income
-22.32B-146.12%
Cash from operations
-43.49B-129.94%
Cash from investing
162.34B216.43%
Cash from financing
106.40B3,679.52%
Net change in cash
220.71B5,771.01%
Free cash flow
-59.65B-158.77%
About
SK Bioscience is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals. Wikipedia
Founded
Jul 1, 2018
Employees
1,067
Search
Clear search
Close search
Google apps
Main menu